News & Updates

Show Multimedia Only

Children with UI, psychiatric disorder perform poorly in school

10 Jul 2025

Urinary incontinence (UI) does not appear to affect the performance of children in school, reports a recent study.

Children with UI, psychiatric disorder perform poorly in school

10 Jul 2025

Deucravacitinib delivers superior efficacy, safety in active PsA

10 Jul 2025 by

Deucravacitinib exhibits superiority over placebo in terms of overall disease activity measures, musculoskeletal and dermatologic manifestations, and quality of life in adults with active psoriatic arthritis (PsA) who are naïve to biologic disease-modifying antirheumatic drugs (DMARDs), according to the results of the POETYK PsA-1 study.

Deucravacitinib delivers superior efficacy, safety in active PsA

10 Jul 2025

Larger prostate glands improve faster after thermal therapy

10 Jul 2025

Patients with benign prostatic hyperplasia undergoing convective water vapor thermal therapy (CWVTT) enjoy significant improvements in lower urinary tract symptoms (LUTS) across the prostate volume (PV) spectrum. Notably, medium and large glands appear to show faster improvement than small ones.

Larger prostate glands improve faster after thermal therapy

10 Jul 2025

Investigational triple–hormone-receptor agonist reduces fat mass in people with T2D

10 Jul 2025

Treatment with retatrutide—an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors—appears to result in greater total body fat mass reduction in individuals with type 2 diabetes (T2D) and high BMI when compared with placebo and dulaglutide, according to a substudy of a phase II trial.

Investigational triple–hormone-receptor agonist reduces fat mass in people with T2D

10 Jul 2025

ADHD medications’ real-world benefits diminish as prescription rate rises

10 Jul 2025 by

Attention-deficit/hyperactivity disorder (ADHD) medications are associated with reduced risks of several serious real-world outcomes, but the magnitude of these associations has decreased alongside rising prescription rates, a nationwide study has shown.

ADHD medications’ real-world benefits diminish as prescription rate rises

10 Jul 2025

Pembrolizumab + CCRT ups survival in high-risk LACC

10 Jul 2025 by

Treatment with the combination of pembrolizumab and concurrent chemoradiotherapy (CCRT), followed by pembrolizumab maintenance, led to a sustained, long-term survival benefit in patients with high-risk, locally advanced cervical cancer (LACC) compared with CCRT alone, according to the final analysis of the phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial presented at ASCO 2025.

Pembrolizumab + CCRT ups survival in high-risk LACC

10 Jul 2025

SGLT-2 inhibitors may provide liver-related benefits to patients with cirrhosis

09 Jul 2025 by

The use of a sodium-glucose cotransporter 2 (SGLT-2) inhibitor helps lower the incidence of serious liver events among patients with cirrhosis who are receiving diuretic therapy, according to a study.

SGLT-2 inhibitors may provide liver-related benefits to patients with cirrhosis

09 Jul 2025

Does testosterone level predict metastasis-free survival in nmCRPC?

09 Jul 2025

Maintenance serum testosterone levels ≥20 ng/dL do not appear predictive of worse metastasis-free survival (MFS) among men with testosterone <50 ng/dL on first-line therapy of nonmetastatic castration-resistant prostate cancer (nmCRPC) using novel hormonal agents, according to a study.

Does testosterone level predict metastasis-free survival in nmCRPC?

09 Jul 2025

Malays most referred patients to nephrology care in SG

09 Jul 2025 by

A Singapore study has found that patients referred for kidney disease are predominantly Malays, who tend to have higher metabolic disease burden, miss their appointments, and be referred at lower estimated glomerular filtration rate (eGFR).

Malays most referred patients to nephrology care in SG

09 Jul 2025

Defibrillation testing may be omitted in most recipients of S-ICD

09 Jul 2025

The majority of subcutaneous implantable cardioverter defibrillator (S-ICD) recipients may safely forgo defibrillation testing (DT) during implantation, suggests a study. However, selective DT may be considered in those at higher risk.

Defibrillation testing may be omitted in most recipients of S-ICD

09 Jul 2025

News & Updates

Filter by Specialty:

Specialty:

Children with UI, psychiatric disorder perform poorly in school

Children with UI, psychiatric disorder perform poorly in school

Deucravacitinib delivers superior efficacy, safety in active PsA

Deucravacitinib delivers superior efficacy, safety in active PsA

Larger prostate glands improve faster after thermal therapy

Larger prostate glands improve faster after thermal therapy

Investigational triple–hormone-receptor agonist reduces fat mass in people with T2D

Investigational triple–hormone-receptor agonist reduces fat mass in people with T2D

ADHD medications’ real-world benefits diminish as prescription rate rises

ADHD medications’ real-world benefits diminish as prescription rate rises

Pembrolizumab + CCRT ups survival in high-risk LACC

Pembrolizumab + CCRT ups survival in high-risk LACC

SGLT-2 inhibitors may provide liver-related benefits to patients with cirrhosis

SGLT-2 inhibitors may provide liver-related benefits to patients with cirrhosis

Does testosterone level predict metastasis-free survival in nmCRPC?

Does testosterone level predict metastasis-free survival in nmCRPC?

Malays most referred patients to nephrology care in SG

Malays most referred patients to nephrology care in SG

Defibrillation testing may be omitted in most recipients of S-ICD

Defibrillation testing may be omitted in most recipients of S-ICD